• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26926
Medical Device Problem Codes Premature Activation (1484); Failure to Advance (2524); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/19/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that this device was difficult to cross the vessel and prematurely deployed.This 6 x 150 x 130 innova vascular stent system was selected for use in a stent placement procedure.The device was able to be passed through a 6 fr sheath but would not pass the popliteal vessel.The device was removed, and it was noted that part of the stent was protruding out.The procedure was completed with another of the same device.There were no patient complications.
 
Additional Manufacturer Narrative
Device eval by manufacturer: upon receipt at our post market quality assurance laboratory, this innova vascular stent system was inspected for damage.Visual examination revealed a kink to the sheath at the nosecone.The stent was partially deployed 2mm from the distal end of the middle sheath and was damaged.Microscopic examination revealed no additional damages.The thumbwheel lock and pull rack were still in the manufactured position.Inspection of the remainder of the device, revealed no other damage or irregularities.Product analysis found damage to the device that may have contributed to the premature deployment.
 
Event or Problem Description
It was reported that this device was difficult to cross the vessel and prematurely deployed.This 6 x 150 x 130 innova vascular stent system was selected for use in a stent placement procedure.The device was able to be passed through a 6 fr sheath but would not pass the popliteal vessel.The device was removed, and it was noted that part of the stent was protruding out.The procedure was completed with another of the same device.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA VASCULAR
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17389383
Report Number2124215-2023-39281
Device Sequence Number11731307
Product Code NIP
UDI-Device Identifier08714729874041
UDI-Public08714729874041
Combination Product (Y/N)N
Initial Reporter StateDE
Initial Reporter CountryUS
PMA/510(K) Number
P140028
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number26926
Device Catalogue Number26926
Device Lot Number0031608193
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 07/19/2023
Supplement Date Received by Manufacturer08/22/2023
Initial Report FDA Received Date07/25/2023
Supplement Report FDA Received Date08/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/12/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-